10.6084/m9.figshare.c.3609956_D5.v1
Thorsten Hartmann
Thorsten
Hartmann
Sabrina Overhagen
Sabrina
Overhagen
D. Ouwens
D.
Ouwens
Silja Raschke
Silja
Raschke
Paulus Wohlfart
Paulus
Wohlfart
Norbert Tennagels
Norbert
Tennagels
Nina Wronkowitz
Nina
Wronkowitz
Jürgen Eckel
Jürgen
Eckel
MOESM3 of Effect of the long-acting insulin analogues glargine and degludec on cardiomyocyte cell signalling and function
Springer Nature
2016
Insulin glargine
Insulin degludec
Cardiac action
Insulin analogues
2016-07-15 05:00:00
Journal contribution
https://springernature.figshare.com/articles/journal_contribution/MOESM3_of_Effect_of_the_long-acting_insulin_analogues_glargine_and_degludec_on_cardiomyocyte_cell_signalling_and_function/4359236
Additional file 3: Figure S2. Phosphorylation of Akt(Thr308) in HL-1 cells. (A-C) HL-1 cells were used to assess the onset of insulin action by treatment with 200 nM for 5 (A); 10 (B) or 60 min (C) with insulin or insulin analogues. Phosphorylation of Akt(Thr308) was assessed by Western blot analysis. Data are normalised to tubulin levels. Representative blots are shown. Data represent mean values ± SEM, n = 3, *p < 0.05 vs. basal, #p < 0.05 vs. IDeg. Regular insulin (Ins), insulin glargine (IGla), active metabolite of insulin glargine (IGlaM1), insulin degludec (IDeg).